medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 1

Rev Invest Clin 2017; 69 (1)


Radiotherapy for Metastatic Breast Cancer in Mexico: Results from the 2015 National Survey

Álvarez-Águila N, Cook H, Prada D, Mota-García A, Herrera LA, Mohar-Betancourt A, Meneses-García A, Knaul FM

Idioma: Ingles.
Referencias bibliográficas: 17
Paginas: 11-19
Archivo PDF: 164.22 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, et al. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012;13:e335-43.

  2. Bray F, Ren J-S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.

  3. Stewart BW, Wild CP. World Cancer Report 2014. Available at: http://publications.iarc.fr/Non-Series-Publications/World-Cancer- Reports/World-Cancer-Report-2014.

  4. A tun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16:1153-86.

  5. Mohar A, Bargalló E, Ramírez MT, Lara F, Beltrán-Ortega A. [Available resources for the treatment of breast cancer in Mexico]. Salud Publica Mex. 2009;51(Suppl 2):s263-9.

  6. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters. 200816:113-23.

  7. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. [Breast cancer in Mexico: an urgent priority]. Salud Publica Mex. 2009;51(Suppl 2):s335-44.

  8. Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015; 114:3-10.

  9. Walsh SM, Lowery AJ, Prichard RS, McDermott EW, Evoy D, Geraghty J. Postmastectomy radiotherapy: indications and implications. Surgeon. 2014;12:310-15.

  10. Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 2006;7:584-95.

  11. N igenda G, Caballero M, González-Robledo LM. [Access barriers in early diagnosis of breast cancer in the Federal District and Oaxaca]. Salud Publica Mex. 2009;51(Suppl 2):s254-62.

  12. Comparing more than two proportions. Boston University School of Public Health; Available at: http://sphweb.bumc.bu.edu/otlt/ MPH-Modules/BS/R/R6_CategoricalDataAnalysis/R6_Catego ricalDataAnalysis6.html [Accessed 2016 Jan 29].

  13. Poitevin-Chacón A, Hinojosa-Gómez J. Patterns of care of radiotherapy in México. Rep Pract Oncol Radiother. 2012;18: 57-60.

  14. Kong W, Jarvis C, Mackillop WJ. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach. Clin Oncol (R Coll Radiol). 2015;27:83-91.

  15. G il-Gil MJ, Martinez-Garcia M, Sierra A, et al. Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. Clin Transl Oncol. 2014;16: 436-46.

  16. Dixon P, Mackillop W. Could changes in clinical practice reduce waiting lists for radiotherapy? J Health Serv Res Policy. 2001;6: 70-7.

  17. Comisión Nacional de Seguridad Nuclear y Salvaguardias (CNSNS). Available at: http://www.cnsns.gob.mx/ [Accessed 2016 Nov 29].




2020     |     www.medigraphic.com